| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| The Effects of Moviprep With Simethicone on Colonic Bubbles [NCT01209806] | | 140 participants (Actual) | Interventional | 2009-11-30 | Completed |
| Daily Mablet-treatment of Patients With COPD [NCT01118936] | | 11 participants (Actual) | Interventional | 2010-10-31 | Completed |
| A Phase 1, Open-label, Randomized, 3-Period, Relative Bioavailability Study Comparing the Pharmacokinetics of Granule and Tablet Formulations of Deferitazole (Disodium Salt) and a Capsule Formulation of Deferitazole (Magnesium Hydroxide Salt), Each Admini [NCT02065401] | Phase 1 | 0 participants (Actual) | Interventional | 2014-02-28 | Withdrawn(stopped due to This study was withdrawn until the evaluation of the nonclinical rat findings is complete.) |
| ERX1000 - A Phase I, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Male and Female Subjects With Obesity [NCT04890873] | Phase 1 | 48 participants (Actual) | Interventional | 2019-10-17 | Completed |
| Pharmacokinetics and Metabolism of a Single Dose of [14C] BMS-986256 in Healthy Male Participants [NCT04269356] | Phase 1 | 8 participants (Actual) | Interventional | 2020-02-18 | Completed |
| Metacholine-provocation of Mablet-treated Asthmatics [NCT01118923] | | 12 participants (Actual) | Interventional | 2010-10-31 | Completed |
| A Phase 1, Open-Label, 3-Period Crossover Study Of The Effect Of An Antacid, A Proton Pump Inhibitor And An H2-Receptor Antagonist On Palbociclib (PD-0332991) Bioavailability Under Fed Conditions In Healthy Volunteers [NCT02097329] | Phase 1 | 27 participants (Actual) | Interventional | 2014-04-30 | Completed |
| OMAMA-study - Prevention of Opioid-induced Constipation in Patients With Advanced Cancer [NCT05216328] | Phase 4 | 330 participants (Anticipated) | Interventional | 2022-12-02 | Recruiting |
| Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease - A Dose-Finding Trial [NCT02216877] | Phase 1/Phase 2 | 36 participants (Actual) | Interventional | 2014-08-31 | Completed |
| RELISTOR's Effects on Opioid-Induced Constipation in Postoperative 1-2 Level Anterior Lumbar Interbody Fusion Patients: A Case-Control Study [NCT04930237] | | 0 participants (Actual) | Observational | 2021-07-01 | Withdrawn(stopped due to PI request to close study) |
| An Open-Label, 3-Period, Fixed-Sequence, Study to Examine the Effect of Aluminum Hydroxide/Magnesium Hydroxide/Simethicone and Omeprazole on the Single-Dose Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult Subjects [NCT04368585] | Phase 1 | 20 participants (Actual) | Interventional | 2020-07-01 | Completed |
| The Impact of Air Travel on Passenger Cognitive Functions [NCT04802785] | Phase 2/Phase 3 | 50 participants (Anticipated) | Interventional | 2021-06-30 | Not yet recruiting |
| The Use of Methylnaltrexone to Reduce Post-operative Opioid-induced Constipation in the Pediatric Spinal Fusion Patient [NCT01773096] | Phase 4 | 60 participants (Anticipated) | Interventional | 2013-05-31 | Completed |
| Interventional, Randomized, Open-Label, Crossover, Single-Dose, Relative Bioavailability Study Comparing Two Pharmaceutical Formulations of Lu AG06466 and Investigating the Food Effect on Lu AG06466 in Healthy Subjects [NCT05028673] | Phase 1 | 16 participants (Actual) | Interventional | 2021-08-23 | Completed |
| A Single-Dose, Open-Label, Three-Period Crossover Study to Assess the Bioequivalence of Famotidine/Antacid Combination Tablets (FACT) Compared to Famotidine/Antacid EZ Chew Tablet Without Water and Famotidine/Antacid EZ Chew Tablet With Water [NCT00944671] | Phase 1 | 24 participants (Actual) | Interventional | 2008-02-29 | Completed |
| A Phase II, Randomized, Double-blind, Placebo-controlled, Parallel Group Proof-of-Concept Trial to Assess Relief of Meal Induced Heartburn by a Combination of Lansoprazole 15 mg and Antacid Versus Lansoprazole 15 mg and Antacid (Calcium Carbonate and Magn [NCT01037452] | Phase 2 | 120 participants (Actual) | Interventional | 2009-12-31 | Completed |
| A Three-Part Phase 1 Study to Evaluate the Potential Drug Interaction Between ACH-0144471 and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adult Subjects [NCT05109390] | Phase 1 | 72 participants (Actual) | Interventional | 2018-07-27 | Completed |
| Clinical Trial to Assess the Efficacy of Fixed Combination Product Tepilta® in the Treatment of Radiation-induced Oesophagitis Compared to Its Active Ingredients Oxetacaine and Antacids, and to Placebo [NCT01336530] | Phase 3 | 40 participants (Actual) | Interventional | 2011-04-30 | Terminated(stopped due to The study stopped prematurely due to and administrative reasons, not based on grounds of safety.) |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |